The appeal of triple-action therapy is that it may address multiple pathways simultaneously
GLP-1 (glucagon-like peptide-1) receptor agonists are medications used primarily to treat type 2 diabetes and support weight loss
Incretin-based therapies for type 2 diabetes mellitus
Effect of DPP-4 inhibitor on elderly patients with T2DM combined with MCI
In preclinical models, acetyl-L-carnitine reduced brain oxidative damage markers including malondialdehyde, oxidized nucleotides, and nitrotyrosine, while L-carnitine at equivalent doses did not, despite both similarly elevating tissue carnitine levels and improving ambulatory activity.[1] Acetyl-L-carnitines superior CNS effects likely reflect its ability to donate acetyl groups for energy production, neurotransmitter synthesis, and direct antioxidant activity.[2][3] For systemic inflammation, L-carnitine demonstrates clear clinical efficacy
This treatment is based on cutting-edge scientific research that demonstrates how these antioxidants can significantly improve markers of exercise efficiency and recovery